Cardiac Parameters and Interleukin-6 Differences between Adolescents with Hepatitis B Infection versus those Complicated with Hepatocelluar Carcinoma
| Autor: | Hosam El Din Mostafa Seleem, Waleed M. El-Guindy, Thoraya A.M. Hosny, Sameh M Abdel Monem |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Hepatitis B virus
medicine.medical_specialty biology medicine.diagnostic_test Computer Networks and Communications business.industry Physical examination Anthropometry medicine.disease medicine.disease_cause digestive system diseases Hepatitis B infection Hardware and Architecture Hepatocellular carcinoma Internal medicine biology.protein medicine Risk factor Interleukin 6 business Software Hepatocelluar carcinoma |
| Zdroj: | Afro-Egyptian Journal of Infectious and Endemic Diseases. 8:68-73 |
| ISSN: | 2090-7184 |
| Popis: | Background and study aim: Hepatitis B virus (HBV) is a major risk factor of hepatocellular carcinoma (HCC) in all age groups. There is a need to differentiate between them in the adolescence age by laboratory and physical examination for assessment of different outcomes of both diseases. Subjects and Methods: Cross sectional study that included Session [UserIDID] adolescents with HBV, another Session [UserIDID] with HCC with age ranging from 12 and up to 17 years. They were selected from those admitted to Tropical Medicine Department, Menofia University and Tropical Medicine Department, Zagazig University. All patient underwent laboratory assessment of interleukin6 (IL6) and were further examined at the Cardiology Unit in Pediatric department of Ain Shams University hospitals for complete echo-cardiographic and anthropometric evaluation. Results: Twenty four patients have HCC were examined with mean age (14.15± 3.01) years and another Session [UserIDID] are having HBV (14.64±3.13) years. Differences were found between both groups as regards IL6 as mean values were (13.29 pg/ml) in HBV and (77.63 pg/ml) in HCC group while no differences were detected as regards cardiac and anthropometric evaluations. Conclusion: IL6 seems to be a useful marker to compare between HBV and HCC in adolescent patients instead of depending on clinical cardiac evaluation or growth parameters that showed no differences. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|